
The healthcare crisis none of us can afford
That was the key insight from our recent survey on mental and financial health we conducted with Talker Research. About 70% of U.S. adults said their financial anxiety is at an all-time high, and 20% reported a decline in their mental health over the past year.
If that weren't alarming enough, roughly 30% of people said their mental health had been negatively impacted by the cost of healthcare, or by the difficulty of accessing healthcare for themselves or a loved one. Most discouraging, despite the evident need, only 14% of people were currently seeing a therapist or psychiatrist. The top reason people cited for not getting help? Affordability, by a wide margin.
Costs are rising
This tangle of financial anxiety, cost-related access barriers and deteriorating mental health are a crisis in the making for all of us. When people forgo needed care or medications due to cost—as 36% of Americans recently have—their physical and mental health problems tend to get worse, which makes them more likely to end up in the emergency room or a hospital bed.
This cycle is an especially acute problem in the commercial insurance market, which largely comprises employers providing health benefits to America's workforce (158 million people). Thanks in part to surging hospital prices, per-capita healthcare spending has shot up faster in the commercial market than in Medicare or Medicaid—and the cost trend is only getting steeper.
Cumulative growth in per capita spending by insurance type since 2008
Employee benefits
Rising costs are trickling down to individuals and families through higher premiums and copays, even though employers, to their credit, have absorbed most of the increases in recent years. In fact, in an effort to support their workforce and rein in costs, many employers have upped their investment in a wide range of health benefits—often at little or no cost to employees—to close gaps in care and guide their people toward high-quality, cost-effective support. These benefits range from mental health apps, platforms for telehealth and chronic condition management, navigation services, and much, much more.
While some of these offerings do help individuals get healthier and generate cost savings, it's clear they haven't done enough to reverse the broader affordability trend. How come?
Engagement is one problem. Too few employees are aware of their benefits, enroll in them, or stick with them long enough to impact their health or financial outcomes. Employee engagement is always an uphill battle, and the lack of integration in healthcare only makes it harder. Mental, physical, and financial health can't be addressed in isolation, as the recent survey findings show. But most tools and services aren't connected, making it nearly impossible for individuals to experience a seamless journey that supports all of their healthcare needs.
A bigger, related problem is the fee-for-service payment model. Engagement alone—getting people to use more services—won't improve outcomes if the care isn't timely or high quality. In the commercial market, a shift toward value-based care and contracting is helping employers, employees, and healthcare partners align incentives to drive better clinical and financial results for everyone.
What people really need, what they're missing most, is personalized, all-in-one healthcare that provides integrated medical and mental health support, care coordination, benefits guidance, and help with billing and claims, all of it connected by empathetic humans who are looking out for the whole person. Mind, body, wallet. Taking care of any one of these dimensions of health—and bringing down costs for everyone—requires taking care of all three.
Owen Tripp is cofounder and CEO of Included Health.
The early-rate deadline for Fast Company's Most Innovative Companies Awards is Friday, September 5, at 11:59 p.m. PT. Apply today.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Kaul joins multistate suit claiming Trump has sought to deter care of transgender youths
Wisconsin Attorney General Josh Kaul joined a multistate lawsuit Aug. 1 suing the Trump administration for "relentlessly, cruelly and unlawfully" targeting transgender people. The lawsuit, filed in the U.S. District Court for the District of Massachusetts, comes six months after Kaul vowed to pursue legal actions should the federal government attempt to impede funding for gender-affirming health care. Recent federal actions have sought to deter health care providers from treating transgender patients under the age of 19, despite states like Wisconsin having laws in place that allow for medically appropriate procedures. President Donald Trump's Jan. 28 order oversteps its authority, the lawsuit states, by intimidating providers through threats of civil and criminal prosecution. The lawsuit emphasizes the order not only "has no basis in law" but is unconstitutional. Ultimately, the lawsuit is requesting the court to block the administration's actions and cease enforcing the order. 'The Trump administration shouldn't be interfering with the provision of health care,' Kaul said in a press release last week. 'The administration should be respecting individual liberty and equal rights, not shamefully targeting transgender people.' Trump's directive, signed early in his second term, aims to strip funds from medical institutions that provide gender-affirming care, and would require federal health programs like Medicaid and TRICARE (for military families) to exclude coverage of gender-affirming surgeries and hormone treatments for young people by 2026. Gender-affirming medical care supports people whose gender identity is out of sync with the sex they were assigned at birth. Health care may include the use of hormones to delay puberty in adolescents, behavioral health counseling to support and promote the gender identity with which a person aligns, and hormone replacement therapy. In very rare cases for young people, it may involve surgery. Access to gender-affirming services has been associated with lower suicide risks for transgender people. Research has also shown that people encountering anti-transgender bias and a denial of services had more than double the prevalence of suicide attempts than those who didn't have such experiences, according to the Williams Institute. The attorneys general warn the administration's tactics have had a chilling effect on states' ability to provide gender-affirming services. Despite protective laws being on the books, health care providers have already scaled back the services they offer to transgender youth. Other gender clinics have shuttered services completely in an attempt to avoid civil or criminal investigations and actions. Joining Kaul in filing this lawsuit are the attorneys general of California, Connecticut, Delaware, Hawai'i, Illinois, Maine, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New Mexico, New York, Rhode Island, and the District of Columbia, as well as the Governor of Pennsylvania. Natalie Eilbert covers mental health issues for the Milwaukee Journal Sentinel. She welcomes story tips and feedback. You can reach her at neilbert@ or view her X (Twitter) profile at @natalie_eilbert. This article originally appeared on Milwaukee Journal Sentinel: Wisconsin AG Kaul joins suit claiming Trump deters transgender care Solve the daily Crossword

Yahoo
2 hours ago
- Yahoo
HealthStream: Q2 Earnings Snapshot
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — HealthStream Inc. (HSTM) on Monday reported net income of $5.4 million in its second quarter. On a per-share basis, the Nashville, Tennessee-based company said it had profit of 18 cents. The provider of internet-based educational and training content for health care professionals posted revenue of $74.4 million in the period. HealthStream expects full-year revenue in the range of $297.5 million to $303.5 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on HSTM at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Addus HomeCare (NASDAQ:ADUS) Surprises With Q2 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q2 CY2025 results exceeding the market's revenue expectations , with sales up 21.8% year on year to $349.4 million. Its non-GAAP profit of $1.49 per share was 1.8% above analysts' consensus estimates. Is now the time to buy Addus HomeCare? Find out in our full research report. Addus HomeCare (ADUS) Q2 CY2025 Highlights: Revenue: $349.4 million vs analyst estimates of $346.5 million (21.8% year-on-year growth, 0.8% beat) Adjusted EPS: $1.49 vs analyst estimates of $1.46 (1.8% beat) Adjusted EBITDA: $43.93 million vs analyst estimates of $43.08 million (12.6% margin, 2% beat) Operating Margin: 9.4%, in line with the same quarter last year Sales Volumes rose 32.7% year on year (-2.8% in the same quarter last year) Market Capitalization: $1.91 billion Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, 'Addus delivered another strong financial and operating performance for the second quarter of 2025, as we continued to execute our strategy with consistent and favorable results. Notably, our net service revenue for the second quarter of 2025 was up 21.8% year-over-year, and adjusted EBITDA increased 24.5% over the same period last year. These results reflect solid organic growth and include the additional revenue from the personal care operations of Gentiva, which we acquired on December 2, 2024. We continue to see robust demand for our services, reflecting the growing recognition of the value and cost-effectiveness of home-based care. With our proven operating model across the continuum of care and expanding scale in key markets, Addus is well positioned to meet this demand and continue to capitalize on additional growth opportunities. Company Overview Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ:ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals. Revenue Growth A company's long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Thankfully, Addus HomeCare's 11.6% annualized revenue growth over the last five years was decent. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Addus HomeCare's annualized revenue growth of 12.9% over the last two years is above its five-year trend, suggesting its demand recently accelerated. We can better understand the company's revenue dynamics by analyzing its number of average billable patients, which reached 50,404 in the latest quarter. Over the last two years, Addus HomeCare's average billable patients averaged 12% year-on-year growth. Because this number is in line with its revenue growth, we can see the company kept its prices fairly consistent. This quarter, Addus HomeCare reported robust year-on-year revenue growth of 21.8%, and its $349.4 million of revenue topped Wall Street estimates by 0.8%. Looking ahead, sell-side analysts expect revenue to grow 12.9% over the next 12 months, similar to its two-year rate. This projection is healthy and suggests the market is baking in success for its products and services. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It's also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes. Addus HomeCare was profitable over the last five years but held back by its large cost base. Its average operating margin of 8.1% was weak for a healthcare business. On the plus side, Addus HomeCare's operating margin rose by 2.6 percentage points over the last five years, as its sales growth gave it operating leverage. Zooming in on its more recent performance, we can see the company's trajectory is intact as its margin has also increased by 1.3 percentage points on a two-year basis. This quarter, Addus HomeCare generated an operating margin profit margin of 9.4%, in line with the same quarter last year. This indicates the company's overall cost structure has been relatively stable. Earnings Per Share Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Addus HomeCare's spectacular 13.4% annual EPS growth over the last five years aligns with its revenue performance. This tells us its incremental sales were profitable. In Q2, Addus HomeCare reported adjusted EPS at $1.49, up from $1.35 in the same quarter last year. This print beat analysts' estimates by 1.8%. Over the next 12 months, Wall Street expects Addus HomeCare's full-year EPS of $5.59 to grow 14.7%. Key Takeaways from Addus HomeCare's Q2 Results It was good to see Addus HomeCare narrowly top analysts' revenue and EPS expectations this quarter. On the other hand, its sales volume slightly missed. Overall, this was still a decent quarter. The stock traded up 1.5% to $108.75 immediately after reporting. So should you invest in Addus HomeCare right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio